Abstract
A fixed-dose combination tablet of the hepatitis C virus (HCV) NS3/4A protease inhibitor (PI) glecaprevir and the HCV NS5A inhibitor pibrentasvir [gle......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
